Amino Acid Analysis for Cell and Gene Therapy Processes
Free amino acid and ammonia profiles from T-cell, NK-cell and iPSC expansion and from HEK293 viral vector runs, so you can tell whether a feed, perfusion rate or medium exchange is set by a nutrient or by waste.
Sample prep: liquid samples are spun, derivatized and injected; solids and powders go through solids preparation (PREP-1, +$30 per sample).
On this page
We measure free amino acids and ammonia in spent media from T-cell, NK-cell and iPSC expansion and HEK293 viral vector runs. The profile shows whether a feed, perfusion rate or medium exchange is set by a nutrient or by waste. Results come in µM and mg/L; the AA-1 profile is $150 per sample. Send 200 µL of clarified medium per sample, with 400 µL preferred. Overnight turnaround available, with expedited service on request. Standard results in 3 to 5 business days from receipt. Not GMP: use results for development and feed decisions. For a whole run, the RUN-1 package covers up to 24 time points for $1,990.
Cell therapy and viral vector processes run in small volumes and often in serum-free media, and the spent medium is the most direct record of what the cells used. In a recent perfusion study of CAR-T expansion in stirred-tank bioreactors, viability fell below 90% when lactate stayed above about 15 mmol/L for more than 48 hours. The authors add that amino acid analyses, which they did not perform, "may also inform on potential targeted supplementation strategies" 3. A free amino acid and ammonia profile fills that gap.
What we measure in cell and gene therapy media
T and NK cells. In a 21-day CAR-T expansion, analysis of the supernatants showed significant consumption of all amino acids in the medium during the first 12 days, and minimal consumption after day 14 2. Ammonia can build up quickly. When T cells were held concentrated for 6 hours, ammonium rose to 3.5 mM at room temperature and 4 mM at 37 °C, and the ammonium level correlated with greatly decreased later expansion and day-13 viability 1. In that study glutamine was not limiting: at most 0.5 mM was consumed 1. In an NK-92 cell line grown in 2 L stirred bioreactors, ammonia ended at 1.95–2.48 mM, while glucose and glutamine did not reach limitation during growth 5.
Pluripotent stem cells. Human iPSCs in mTeSR1 medium consumed arginine, cystine, glutamine and serine heavily over 3 days, and tryptophan was the most consumed of all the amino acids tested 6. In stirred-tank expansion of human pluripotent stem cells, no amino acid ran out, glutamine included, while glutamate, alanine and to some extent glycine accumulated, more so under repeated-batch feeding 7. Perfusion in the same study raised the average density by 47% over repeated batch 7.
Viral vectors. In lentiviral vector production by stable producer clones induced at high density, HPLC analysis of spent media showed that amino acids and glucose were not depleted and that lactate and ammonia were in a normal range. That ruled those components out as the cause of lower productivity 8. Blending media and feeds from different suppliers then raised lentiviral productivity by up to fivefold 8. In AAV production by transfection, exchanging the medium at transfection correlated clearly with higher production. The authors proposed nutrient limitation or by-product accumulation as the cause but did not measure metabolites 9.
| Analytes | Why they matter in these processes | Panel |
|---|---|---|
| Ammonia, glutamine, glutamate | Ammonium after a concentrated T-cell hold tracked poorer later expansion 1; NK-92 runs ended near 2–2.5 mM ammonia 5 | AA-1 |
| Arginine, histidine, tryptophan and the other essential amino acids | Consumed throughout the first 12 days of CAR-T expansion 2; tryptophan was the most consumed amino acid in iPSC culture 6 | AA-1 |
| Serine | Heavily consumed by iPSCs 6 | AA-1 |
| Alanine, glutamate, glycine | Accumulated in stirred-tank pluripotent stem cell culture, more under repeated-batch feeding 7 | AA-1 |
| Cysteine, cystine | Cysteine fell during a concentrated T-cell hold 1; cystine was heavily consumed by iPSCs 6 | AA-3, after a free call |
We derivatize free amino acids with AQC, separate them by reversed-phase HPLC and detect them with dual UV (260 nm) and fluorescence detection, which together confirm each peak and give richer information; see how AQC derivatization works. The same chemistry was used to measure 19 amino acids and ammonium in the T-cell study above 1. Results come in µM and mg/L, with an internal standard in every sample and a QC standard in every run. Tell us your sample count and type, and we'll confirm timing. Lactate and glucose are not on our panel, so read our results alongside your analyzer data. Our work supports research, development and process monitoring. We are not yet accredited (ISO 17025, GLP or GMP).
Questions this answers
- "Is our perfusion rate or feed limited by an amino acid, or only by lactate?"
- "Does ammonium build up during our wash, hold or expansion steps, and does that track with poorer expansion?"
- "On which day does amino acid uptake level off, so we can time the last feed or the harvest?"
- "Can our iPSC process move from daily full medium exchange to less frequent feeding without running short of glutamine, serine or tryptophan?"
- "When we transfect at high cell density, is lost vector productivity caused by a depleted amino acid, or do we need a medium exchange?"
- "Is the ammonia we measure coming from the cells, from warmed glutamine-containing medium, or from how the samples were stored?"
Caveats for this matrix
Glutamine turns into ammonia without any cells
Glutamine in medium breaks down to ammonia on its own. In one study, pre-warming medium or storing it at room temperature produced over 20-fold more ammonium than in fresh medium, while media without L-glutamine or with GlutaMAX stayed close to the detection limit 10. Send a sample of fresh medium, handled the same way as your culture samples, so the chemical share of the ammonia can be separated from what the cells produced.
Alanyl-glutamine is not free glutamine
Many cell therapy media supply glutamine as the dipeptide alanyl-glutamine (GlutaMAX). In a 21-day CAR-T expansion it was entirely cleaved over the run 2. AA-1 reports free glutamine and free alanine. The intact dipeptide is not counted as glutamine, so low free glutamine early in a dipeptide-fed culture does not by itself mean the glutamine source is used up.
Store samples the same way, and freeze them promptly
Ammonia is volatile. In a CAR-T sampling study, samples kept in a refrigerator had significantly lower ammonia than samples frozen immediately, and the authors suggest ammonia evaporated during storage 4. Freeze samples promptly after collection, keep them capped, and store every sample in a time course the same way.
Serum, platelet lysate and albumin
Human serum, platelet lysate, albumin and cytokine carriers add protein, and protein carries amine groups that react with AQC. We remove protein before derivatization and run a spike-recovery check the first time we see a new medium (PREP-2). Cysteine and cystine are not part of AA-1; AA-3 is on request. Results below the quantitation limit are flagged, not reported as numbers. See sample preparation and how we control quality.
Key papers
- Impacts of transient exposure of human T cells to low oxygen, temperature, pH and nutrient levels relevant to bioprocessing for cell therapy applications Kunitskaya A, Piret JM, Cytotherapy, 2025Cited for: T and NK cells.
- Mapping real-time metabolic kinetics of expanded CAR T cells using hyperpolarized 13C-glucose and metabolomics Jensen PR, Mathiassen TBW, Hansen MR, et al., Scientific Reports, 2025Cited for: T and NK cells.
- Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors Springuel P, Hood T, Slingsby F, et al., Frontiers in Bioengineering and Biotechnology, 2025Cited for: Cell therapy and viral vector processes run in small volumes and often in serum-free media, and the spent medium is the most direct record of what the cells used.
- Automated, aseptic sampling with small-volume capacity from microbioreactors for cell therapy process analysis Chan ZX, Chelvam SP, Sin WX, et al., Frontiers in Bioengineering and Biotechnology, 2025Cited for: Ammonia is volatile.
Latest research
New papers on this topic, newest first. We check PubMed every month; last checked October 2026.
-
Mass Spectrometry in Allogeneic CAR-T Cell Manufacturing: From Cellular Starting Materials to Multi-Attribute Quality Control
Cells
Reviews mass spectrometry uses across allogeneic CAR-T manufacturing, including in-process monitoring of metabolites and culture and spent-media composition.
-
Advanced spent media analytics and multivariate data analysis for AAV production media optimization
J Chromatogr A
Untargeted spent-media metabolomics and modeling across four HEK293 media found 37 compounds linked to AAV2 titer. Adding nicotinic acid raised genomic titer.
-
A novel cultivation strategy to recover NK cell cytotoxicity
Front Bioeng Biotechnol
NK-92 cells lost cytotoxicity as lactate built up in batch culture. A fresh-medium recovery phase restored cytotoxicity and scaled to a 2 L bioreactor.
-
Mapping real-time metabolic kinetics of expanded CAR T cells using hyperpolarized 13C-glucose and metabolomics
Sci Rep
NMR monitoring of CAR T expansion media showed glucose depletion peaked in week one. Amino acids were heavily consumed, and consumption declined after day 12.
Key references
- Impacts of transient exposure of human T cells to low oxygen, temperature, pH and nutrient levels relevant to bioprocessing for cell therapy applications: Kunitskaya A, Piret JM, Cytotherapy, 2025.
- Mapping real-time metabolic kinetics of expanded CAR T cells using hyperpolarized 13C-glucose and metabolomics: Jensen PR, Mathiassen TBW, Hansen MR, et al., Scientific Reports, 2025.
- Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors: Springuel P, Hood T, Slingsby F, et al., Frontiers in Bioengineering and Biotechnology, 2025.
- Automated, aseptic sampling with small-volume capacity from microbioreactors for cell therapy process analysis: Chan ZX, Chelvam SP, Sin WX, et al., Frontiers in Bioengineering and Biotechnology, 2025.
- Homogeneous shear distribution improves NK-92 cell cytotoxicity in a clinically relevant 2 L membrane-stirred bioreactor, von Werz V, van Heuvel Y, Hadrbolec M, et al., Frontiers in Bioengineering and Biotechnology, 2026.
- Tryptophan metabolism regulates proliferative capacity of human pluripotent stem cells: Someya S, Tohyama S, Kameda K, et al., iScience, 2021.
- Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors: Kropp C, Kempf H, Halloin C, et al., Stem Cells Translational Medicine, 2016.
- Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density: Shen CF, Tremblay S, Sabourin-Poirier C, et al., Bioprocess and Biosystems Engineering, 2022.
- AAV process intensification by perfusion bioreaction and integrated clarification: Mendes JP, Fernandes B, Pineda E, et al., Frontiers in Bioengineering and Biotechnology, 2022.
- Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses: Kegel NB, Kaufmann A, Matrosovich M, Bauer S, Dorna J, Virology, 2025.
OpenChemWorks Laboratory · Reviewed by the OpenChemWorks laboratory · Updated November 19, 2026
Keep exploring
Related pages: the method behind these results, and the matrices closest to yours.
Have samples in mind?
Pick the tests, the sample type and any preparation. The total updates as you go, and you can book in the same place. Every report includes the chromatogram and QC behind the numbers.
- Free amino acids$150
- Total amino acids$230
- Creatine$120